FATE THERAPEUTICS INC Operating Leases, Rent Expense
FATE THERAPEUTICS INC (FATE) reported Operating Leases, Rent Expense of $2.30 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-02-24
- FATE THERAPEUTICS INC operating leases, rent expense for fiscal 2018 was $2.30M, a 0.00% change from fiscal 2017.
- FATE THERAPEUTICS INC operating leases, rent expense for fiscal 2017 was $2.30M, a 76.92% increase from fiscal 2016.
- FATE THERAPEUTICS INC operating leases, rent expense for fiscal 2016 was $1.30M, a 8.33% increase from fiscal 2015.
- FATE THERAPEUTICS INC operating leases, rent expense for fiscal 2015 was $1.20M, a 33.33% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 80 month |
|---|---|---|
| 2018-12-31 | $2.30M 10-K · filed 2021-02-24 | |
| 2017-12-31 | $2.30M 10-K · filed 2020-03-02 | |
| 2016-12-31 | $1.30M 10-K · filed 2019-03-05 | |
| 2015-12-31 | $1.20M 10-K · filed 2018-03-05 | |
| 2014-12-31 | $900.00K 10-K · filed 2017-03-16 | |
| 2013-12-31 | $900.00K 10-K · filed 2016-03-03 | $3.80M 10-K · filed 2014-03-17 |
| 2012-12-31 | $700.00K 10-K · filed 2015-03-12 | |
| 2011-12-31 | $700.00K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |